Found "Vaccines": 76 results
Sort by
Relevance

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower- Middle Income Country? A Cost-Utility Analysis in the Philippines (2015)

Manuel Alexander Haasis1*, Joyce Anne Ceria1, Wantanee Kulpeng2, Yot Teerawattananon2, Marissa Alejandria3 1 National Center for Pharmaceutical Access and Management (NCPAM), Department of Health, Manila, Philippines, 2 Health Intervention and Technology Assessment Program (HITAP), Department of

A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines (2016)

Kittiphong Thiboonboon1 , Benjarin Santatiwongchai1 ,Varit Chantarastapornchit1 , Waranya Rattanavipapong1 , Yot Teerawattananon1 Abstract Background For more than three decades, the number and influence of economic evaluations of healthcare interventions have been increasing and gaining atte

Economic evaluation of rotavirus vaccination in children of Bhutan

Abstract Background: Diarrhoea remains one of the top ten causes of under-five child morbidity in Bhutan, and rotavirus is a significant cause of child diarrhoeal hospitalisations. This study sought to determine the health outcomes, cost-effectiveness, and budget and human resource implications o

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance

The Thai government implemented COVID-19 booster vaccines to prevent morbidity and mortality during the spreading of the Omicron variant. However, little is known about which types of vaccine should be invested in as the booster dose for the Thai population. This study aims to investigate the most c

Economic Evaluation of Evusheld® for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand

The introduction of Coronavirus disease 2019 (COVID-19) vaccines urged all Thais to seek prevention of serious illness and death from COVID-19. However, immunocompromised individuals might not be able to achieve an efficient immune response from these vaccines. This study aimed to evaluate the cost-

Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?

In many countries, rotavirus vaccination is the most cost-effective way to prevent rotavirus diarrhea. With this in mind, the Essential Medicines and Technology Division (EMTD) in collaboration with Health Intervention Technology Assessment Program (HITAP), Mahidol Oxford Research Unit (MORU), and P

Flu vaccines for all children

All two to 17-year-olds in the UK are to be offered annual flu vaccinations.If 30% take up the offer, there will be 11,000 fewer hospitalisations and 2,000 fewer deaths each year, the chief medical officer for England says.The children will be immunised using a nasal spray rather than an injection,

India to establish Medical Technology Assessment Board

Rhythma Kaul / Hindustand TimesNew Delhi: India announced the setting up of a Medical Technology Assessment Board (MTAB) that will be one-stop shop to review standards for medicines, vaccines, devices and insurance.The Board’s recommendations will be the last word for health policies and healthcare
10 / Page